DopAmide
Dopaminergic agent
From Wikipedia, the free encyclopedia
DopAmide, or L-DopAmide, is a synthetic levodopa (L-DOPA) analogue that can serve as a levodopa and dopamine prodrug and is of potential interest in the treatment of Parkinson's disease.[1][2][3] DopAmide has an amide rather than the carboxyl group of L-DOPA,[2][3] which imparts greater water solubility.[1][2][3] The amide is hydrolyzed back to the acid by aminopeptidase enzymes.[1][2][3]
Other namesL-DopAmide; 3-Hydroxytyrosinamide
| |
| Clinical data | |
|---|---|
| Other names | L-DopAmide; 3-Hydroxytyrosinamide |
| Drug class | Monoamine precursor; Dopamine receptor agonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C9H12N2O3 |
| Molar mass | 196.206 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
